Therapeutic Cooling for Neonates with Hypoxic Brain Injury

Therapeutic cooling, also known as therapeutic hypothermia, is a medical procedure that involves deliberately lowering a patient’s body temperature to cool the brain and prevent brain damage. This procedure has been proposed for several therapeutic uses, including neuroprotection during open-heart and neurosurgical procedures, in patients following a return of spontaneous circulation post-ventricular fibrillation arrest, in patients with trauma head injuries, in patients who have suffered acute ischemic stroke, and in neonates with moderate to severe hypoxic ischemic encephalopathy (HIE). However, the only use whose efficacy has been consistently proven in existing literature is the use of therapeutic cooling in neonates.

The use of therapeutic cooling in carefully selected term neonates with moderate to severe HIE has been recommended as standard care by the National Institute for Health and Care Excellence (NICE). It has been shown in studies to decrease mortality and improve the neurological and neurodevelopmental outcomes of treated neonates. Hypoxic perinatal brain injury is caused by a decrease in the amount of oxygen supplied to an infant’s brain just prior to, or during the process of, labor. Neonates who survive a hypoxic brain injury can develop HIE, which occurs in an estimated 2.5/1000 term births in developed countries and 26/1000 term births in the developing world.

Therapeutic cooling remains the only intervention shown to reduce neuronal damage caused by perinatal hypoxia. The procedure is thought to influence the extent of secondary neuronal death in a multifactorial manner, although the exact way in which it achieves this is not fully understood. The procedure involves placing the infant on a cooling blanket or mattress circulated with coolant fluid or circulating cold water in a cap fitted around the head. Temperature is continuously monitored throughout the treatment using either a rectal or nasopharyngeal thermometer. Close surveillance of infants during the cooling process is required given the risk for complications of both HIE and the process of cooling itself.

The UK immunisation schedule recommends certain vaccines at different ages. At birth, the BCG vaccine is given if the baby is at risk of tuberculosis. At 2, 3, and 4 months, the ‘6-1 vaccine’ (diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B) and oral rotavirus vaccine are given, along with Men B and PCV at certain intervals. At 12-13 months, the Hib/Men C, MMR, and PCV vaccines are given, along with Men B. At 3-4 years, the ‘4-in-1 preschool booster’ (diphtheria, tetanus, whooping cough and polio) and MMR vaccines are given. At 12-13 years, the HPV vaccination is given, and at 13-18 years, the ‘3-in-1 teenage booster’ (tetanus, diphtheria and polio) and Men ACWY vaccines are given. Additionally, the flu vaccine is recommended annually for children aged 2-8 years.

It is important to note that the meningitis ACWY vaccine has replaced meningitis C for 13-18 year-olds due to an increased incidence of meningitis W disease in recent years. The ACWY vaccine will also be offered to new students (up to the age of 25 years) at university. GP practices will automatically send letters inviting 17-and 18-year-olds in school year 13 to have the Men ACWY vaccine. Students going to university or college for the first time as freshers, including overseas and mature students up to the age of 25, should contact their GP to have the Men ACWY vaccine, ideally before the start of the academic year.

It is worth noting that the Men C vaccine used to be given at 3 months but has now been discontinued. This is because the success of the Men C vaccination programme means there are almost no cases of Men C disease in babies or young children in the UK any longer. All children will continue to be offered the Hib/Men C vaccine at one year of age, and the Men ACWY vaccine at 14 years of age to provide protection across all age groups.

The Thoracic Duct: Anatomy and Function

The thoracic duct is a vital component of the lymphatic system, responsible for draining lymph from the lower body, left thorax, and left head and neck regions. Here are some key facts about the thoracic duct:

– Crosses the midline at the level of T5: The thoracic duct ascends behind the right crus and to the right of the aorta and oesophagus. It crosses the midline to the left, posterior to the oesophagus, at the level of T5.
– Drains into the confluence of the right internal jugular and subclavian veins: Correction – the thoracic duct enters the confluence of the left subclavian and internal jugular veins, not the confluence of the right subclavian and internal jugular veins.
– Lies to the right of the oesophagus as it passes through the diaphragm: The thoracic duct does not lie anterior to the oesophagus as it passes through the diaphragm. The thoracic duct ascends to the right of the oesophagus as it passes through the diaphragm.
– Has valves: Valves are present along the duct and encourage the propagation of chyle along the duct. These valves may be unicuspid, bicuspid or tricuspid but are most commonly bicuspid.
– May result in a chylothorax if injured: Injury to the thoracic duct may occur after trauma or during insertion of a central venous catheter on the left-hand side. This can result in a chylothorax (a collection of lymph within the thoracic cavity).

In summary, the thoracic duct plays a crucial role in the lymphatic system, and understanding its anatomy and function is essential for medical professionals.

In case of mild-moderate cow’s milk protein intolerance in a baby who is fed with formula, it is recommended to switch to an extensively hydrolyzed formula.

Understanding Cow’s Milk Protein Intolerance/Allergy

Cow’s milk protein intolerance/allergy (CMPI/CMPA) is a condition that affects around 3-6% of children, typically presenting in the first 3 months of life in formula-fed infants. Both immediate and delayed reactions can occur, with CMPA used for immediate reactions and CMPI for mild-moderate delayed reactions. Symptoms include regurgitation, vomiting, diarrhea, urticaria, atopic eczema, colic symptoms, wheeze, chronic cough, and rarely, angioedema and anaphylaxis. Diagnosis is often clinical, with investigations including skin prick/patch testing and total IgE and specific IgE (RAST) for cow’s milk protein.

Management for formula-fed infants includes using extensive hydrolyzed formula (eHF) milk as the first-line replacement formula for mild-moderate symptoms and amino acid-based formula (AAF) for severe CMPA or if no response to eHF. Around 10% of infants are also intolerant to soya milk. For breastfed infants, mothers should eliminate cow’s milk protein from their diet and consider prescribing calcium supplements to prevent deficiency. eHF milk can be used when breastfeeding stops until at least 6 months and up to 12 months of age.

The prognosis for CMPI is usually good, with most children becoming milk tolerant by the age of 3-5 years. However, a challenge is often performed in a hospital setting as anaphylaxis can occur. It is important to refer infants with severe symptoms to a pediatrician for management. Understanding CMPI/CMPA and its management can help parents and healthcare providers provide appropriate care for affected children.

Investigations for Rapid Cognitive Decline in a Middle-Aged Patient: A Case of Sporadic Creutzfeldt-Jakob Disease

When a patient in their 60s presents with rapid cognitive decline and myoclonic jerks, the possibility of sporadic Creutzfeldt-Jakob disease (sCJD) should be considered. Despite negative findings from other investigations, a lumbar puncture and electroencephalogram (EEG) can support the diagnosis of sCJD. The EEG will show generalised bi- or triphasic periodic sharp wave complexes, while definitive diagnosis can only be made from biopsy. Doppler ultrasound of carotids is relevant for vascular dementia, but the steady decline in this case suggests sCJD. Magnetic resonance imaging (MRI) brain is unlikely to aid diagnosis, and muscle biopsy is unnecessary as myoclonic jerks are a symptom of sCJD. Bone marrow biopsy is only useful if myelodysplastic syndrome is suspected, which is not the case here.

Criteria and Testing for Brain Stem Death

Brain death occurs when the brain and brain stem cease to function, resulting in irreversible loss of consciousness and vital functions. To determine brain stem death, certain criteria must be met and specific tests must be performed. The patient must be in a deep coma of known cause, with reversible causes excluded and no sedation. Electrolyte levels must be normal.

The testing for brain stem death involves several assessments. The pupils must be fixed and unresponsive to changes in light intensity. The corneal reflex must be absent, and there should be no response to supraorbital pressure. The oculovestibular reflexes must be absent, which is tested by injecting ice-cold water into each ear. There should be no cough reflex to bronchial stimulation or gagging response to pharyngeal stimulation. Finally, there should be no observed respiratory effort in response to disconnection from the ventilator for at least five minutes, with adequate oxygenation ensured.

It is important that the testing is performed by two experienced doctors on two separate occasions, with at least one being a consultant. Neither doctor can be a member of the transplant team if organ donation is being considered. These criteria and tests are crucial in determining brain stem death and ensuring that the patient is beyond recovery.

Pancreatic Cell Functions

The pancreas is an important organ in the body that plays a crucial role in regulating blood sugar levels. It is made up of different types of cells that produce various hormones and enzymes. Alpha cells are responsible for producing glucagon, which helps increase blood sugar levels. On the other hand, beta cells produce insulin, which helps lower blood sugar levels. Lastly, PP cells produce pancreatic polypeptide, which helps regulate pancreatic secretion and digestion.

Aside from hormone production, the pancreas also produces enzymes that aid in digestion. Trypsinogen is one of these enzymes, which is produced in the ducts of the exocrine pancreas. It is then converted to trypsin by enzymes found in the gut mucosa. Trypsin plays a crucial role in breaking down proteins in the small intestine, allowing for better absorption of nutrients.

In summary, the pancreas is a complex organ that performs various functions to maintain the body’s overall health. Its different types of cells work together to regulate blood sugar levels and aid in digestion.

FAST scans are a non-invasive method used in trauma to quickly evaluate the presence of free fluid in the chest, peritoneal or pericardial cavities. They are particularly useful in emergency care during the primary or secondary survey to assess the extent of free fluid or pneumothorax. Although CTG is the preferred method for assessing fetal wellbeing, FAST scans can be safely performed in pregnant patients and children, especially in cases of trauma. However, it is important to note that FAST scans have limitations in detecting cardiac tamponade, which requires echocardiography for accurate diagnosis. X-rays and CT scans are more effective in detecting fractures, while FAST scans are specifically designed to identify fluid in the abdomen and thorax. It is important to note that FAST scans cannot be used to assess solid organ injury, and other imaging methods such as formal ultrasound or CT scans are required in such cases.

Trauma management follows the principles of ATLS and involves an ABCDE approach. Thoracic injuries include simple pneumothorax, mediastinal traversing wounds, tracheobronchial tree injury, haemothorax, blunt cardiac injury, diaphragmatic injury, and traumatic aortic disruption. Abdominal trauma may involve deceleration injuries and injuries to the spleen, liver, or small bowel. Diagnostic tools include diagnostic peritoneal lavage, abdominal CT scan, and ultrasound. Urethrography may be necessary for suspected urethral injury.

When considering amenorrhoea, it is important to look at the underlying causes. There are two types: primary and secondary. Primary amenorrhoea occurs when a woman has never had a period, while secondary amenorrhoea occurs when a woman who has previously had periods now hasn’t for at least 6 months (or 12 months if she previously had irregular periods).

In cases of primary amenorrhoea, it is important to consider whether the woman has developed normal secondary sexual characteristics. If she has, then a mechanical obstruction may be the cause rather than a hormonal one. It is unusual for a 17-year-old girl with normal secondary sexual characteristics to have never had a period, so waiting a year before reassessment is not appropriate. Clinical judgement should be used, especially with younger women.

Understanding Amenorrhoea: Causes, Investigations, and Management

Amenorrhoea is a condition characterized by the absence of menstrual periods in women. It can be classified into two types: primary and secondary. Primary amenorrhoea occurs when menstruation fails to start by the age of 15 in girls with normal secondary sexual characteristics or by the age of 13 in girls without secondary sexual characteristics. On the other hand, secondary amenorrhoea is the cessation of menstruation for 3-6 months in women with previously normal and regular menses or 6-12 months in women with previous oligomenorrhoea.

There are various causes of amenorrhoea, including gonadal dysgenesis, testicular feminization, congenital malformations of the genital tract, functional hypothalamic amenorrhoea, congenital adrenal hyperplasia, imperforate hymen, hypothalamic amenorrhoea, polycystic ovarian syndrome, hyperprolactinemia, premature ovarian failure, Sheehan’s syndrome, Asherman’s syndrome, and thyrotoxicosis. To determine the underlying cause of amenorrhoea, initial investigations such as full blood count, urea & electrolytes, coeliac screen, thyroid function tests, gonadotrophins, prolactin, and androgen levels are necessary.

The management of amenorrhoea depends on the underlying cause. For primary amenorrhoea, it is important to investigate and treat any underlying cause. Women with primary ovarian insufficiency due to gonadal dysgenesis may benefit from hormone replacement therapy to prevent osteoporosis. For secondary amenorrhoea, it is important to exclude pregnancy, lactation, and menopause in women 40 years of age or older and treat the underlying cause accordingly. It is important to note that hypothyroidism may also cause amenorrhoea.

Prophylactic Antibiotics for Gut Surgery

Prophylactic antibiotics are commonly used in gut surgery to prevent wound infections, which can occur in up to 60% of cases. The use of prophylactic antibiotics has been shown to significantly reduce the incidence of these infections. Co-amoxiclav is the preferred choice for non-penicillin allergic patients, as it is effective against the types of bacteria commonly found in the gut, including anaerobes, enterococci, and coliforms.

While cefotaxime is often used to treat meningitis, it is not typically used as a prophylactic antibiotic in gut surgery. In patients with mild penicillin allergies, cefuroxime and metronidazole may be used instead. However, it is important to note that cephalosporins should be avoided in elderly patients whenever possible, as they are at a higher risk of developing C. difficile infections. Overall, the use of prophylactic antibiotics is an important measure in preventing wound infections in gut surgery.